Quercis Pharma logo — For a Healthier World

Quercis Pharma

For a Healthier World

Founded 2019 Switzerland Zug, Switzerland 8 employees Private Equity Total: $150.00M Biopharma, Biotechnology +2

General Information

Company Name Quercis Pharma
Founded Year 2019
Location Switzerland Zug, Switzerland
Employees 8
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Private Equity
Business Model B2B, B2C, B2D
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Quercis Pharma. To contact Quercis Pharma, visit quercis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Quercis Pharma compare?

A PDF of Quercis Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Quercis Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Quercis Pharma

Quercis Pharma, established in 2019, is a Swiss-based company rooted deeply in the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries. With the inspiring slogan, "For a Healthier World," Quercis Pharma is pioneering innovative and safe antithrombotic solutions. Their primary mission is to tackle complex diseases inadequately managed by current medical solutions, emphasizing affordable access to their essential therapies.

In a significant boost to their journey, Quercis Pharma secured a notable $150.00M in a Private Equity Round on 09 December 2021. This investment was led by Global Emerging Markets, highlighting strong investor confidence in their potential to innovate within the healthcare space.

For investors focused on groundbreaking advancements in healthcare, Quercis Pharma represents a compelling opportunity with its robust platform and strategic growth trajectory. As it continues to evolve, stakeholders can anticipate its pivotal role in transforming therapeutic solutions globally.

Business keywords: Biopharmaceutical, Novel Antithrombotic Platform, Orphan Diseases, VTE Prevention, Cancer Therapy, Thrombotic Event Treatment, Sickle Cell Disease, Ebola Treatment, COVID-19 Treatment, Safe Medicine, Innovative Treatment, Affordable Access, Late-Stage Clinical Studies, Adverse Event Reduction, Drug Development Pipeline

Services & Products

Research and Development of investigational therapies
Partnership with academic institutions and industry leaders
Expanded Access Programs

Target Customers

Patients in need of lifesaving medicines Healthcare providers Regulatory bodies Patient organizations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round $150.00M 1
Global Emerging Markets
09 Dec 2021

Quercis Pharma Alternatives & Competitors

View All Alternatives
Quercis Pharma vs
Genprex, Inc.
Genprex, Inc. United States

Genprex is a gene therapy company focused on developing life-changing technologies for patients with...

Post-IPO Equity
24 employees
Biopharma, Biotechnology
Quercis Pharma vs
Arcellx
Arcellx United States

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

Acquired
224 employees
Biopharma, Biotechnology
Quercis Pharma vs
uniQure
uniQure The Netherlands

Transforming the lives of patients through gene therapy

IPO
323 employees
Biotechnology, Pharmaceutical

FAQ About Quercis Pharma

For a Healthier World
Quercis Pharma was founded in 2019.
Quercis Pharma is headquartered in Zug, Switzerland.
Quercis Pharma operates in Biopharma, Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Biopharmaceutical, Novel Antithrombotic Platform, Orphan Diseases and VTE Prevention. Its customers include Patients in need of lifesaving medicines, Healthcare providers and Regulatory bodies.
Quercis Pharma has a B2B, B2C and B2D business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Quercis Pharma has approximately 8 employees.
Quercis Pharma has completed 1 funding round, raising a total of $150.00M. The latest funding stage is Private Equity.
Quercis Pharma offers: Research and Development of investigational therapies, Partnership with academic institutions and industry leaders, Expanded Access Programs.
Top alternatives and competitors to Quercis Pharma include Genprex, Inc., Arcellx, uniQure, NEOGAP Therapeutics AB, Targazyme. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quercis Pharma and Genprex, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Quercis Pharma, https://bouncewatch.com/company/quercis-pharma, updated 20 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes